Expeditious Routes to Polycyclic Molecular Frameworks via One-Pot, Two-Step Ugi Ring-Closing Sequences

Zhigang Xu; Fabio De Moliner; Alexandra P. Cappelli; Muhammed Ayaz; Christopher Hulme

doi:10.1055/s-0033-1340219

Synlett, Inhaltsverzeichnis

Synlett 2014; 25(2): 225-228
DOI: 10.1055/s-0033-1340219

letter

Expeditious Routes to Polycyclic Molecular Frameworks via One-Pot, Two-Step Ugi Ring-Closing Sequences

Zhigang Xu

^aDepartment of Pharmacology and Toxicology, College of Pharmacy, BIO5 Oro Valley, The University of Arizona, 1580 E. Hanley Blvd., Oro Valley, AZ 85737, USA Fax: +1(520)6260794 eMail: hulme@pharmacy.arizona.edu

,

Fabio De Moliner

^aDepartment of Pharmacology and Toxicology, College of Pharmacy, BIO5 Oro Valley, The University of Arizona, 1580 E. Hanley Blvd., Oro Valley, AZ 85737, USA Fax: +1(520)6260794 eMail: hulme@pharmacy.arizona.edu

,

Alexandra P. Cappelli

^aDepartment of Pharmacology and Toxicology, College of Pharmacy, BIO5 Oro Valley, The University of Arizona, 1580 E. Hanley Blvd., Oro Valley, AZ 85737, USA Fax: +1(520)6260794 eMail: hulme@pharmacy.arizona.edu

,

Muhammed Ayaz

^aDepartment of Pharmacology and Toxicology, College of Pharmacy, BIO5 Oro Valley, The University of Arizona, 1580 E. Hanley Blvd., Oro Valley, AZ 85737, USA Fax: +1(520)6260794 eMail: hulme@pharmacy.arizona.edu

,

Christopher Hulme*

^aDepartment of Pharmacology and Toxicology, College of Pharmacy, BIO5 Oro Valley, The University of Arizona, 1580 E. Hanley Blvd., Oro Valley, AZ 85737, USA Fax: +1(520)6260794 eMail: hulme@pharmacy.arizona.edu

^bDepartment of Chemistry and Biochemistry, The University of Arizona, Tucson, AZ 85721, USA

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

A very general and robust multicomponent-reaction protocol involving an Ugi condensation between ethyl glyoxylate, isonitriles, N-Boc-α-amino acids, and mono-N-Boc-protected diamines followed by a series of acid-promoted cyclization steps in a one-pot fashion is reported. This process allows for the assembly of complex polycyclic structures by means of just two simple synthetic operations and a single chromatographic purification in high overall yields. Of note, the first scaffolds derived from a highly selective sequence of ring-closing events involving three internal amino nucleophiles is reported.

Key words

multicomponent reaction - nucleophilic attack - heterocycles - isonitriles - one-pot process

Volltext

Referenzen

References and Notes

For recent examples, see:

1a Lian X, Ma S. Chem. Eur. J. 2010; 16: 7960
1b Medley JW, Movassaghi M. Angew. Chem. Int. Ed. 2012; 51: 4572
1c Murata T, Murai M, Ikeda Y, Miki K, Ohe K. Org. Lett. 2012; 14: 2296
1d Chiou WH, Lin YH, Chen GT, Gao YK, Tseng YC, Kao CL, Tsai JC. Chem. Commun. 2011; 47: 3562
1e Gembus V, Janvier S, Lecouvé JP, Vaysse-Ludot L, Brièrea JF, Levacher V. Org. Biomol. Chem. 2012; 10: 2003

For reviews, see:

2a Nicolaou KC, Chen JS. Chem. Soc. Rev. 2009; 38: 2993
2b Malacria M. Chem. Rev. 1996; 96: 289

3a Santra S, Andreana PR. Angew. Chem. Int. Ed. 2011; 50: 9418
3b Ribelin TP, Judd AS, Akritopoulou-Zanze I, Henry RF, Cross JL, Whittern DN, Djuric SW. Org. Lett. 2007; 24: 5119
3c Riva R, Banfi L, Basso A, Cerulli V, Guanti G, Pani M. J. Org. Chem. 2010; 75: 5134

4a De Moliner F, Hulme C. Org. Lett. 2012; 14: 1354
4b Xu Z, De Moliner F, Cappelli AP, Hulme C. Angew. Chem. Int. Ed. 2012; 51: 8037

5 Ugi I, Steinbruckner C. Angew. Chem. 1960; 72: 267

6a Nixey T, Kelly M, Hulme C. Tetrahedron Lett. 2000; 41: 8729
6b Nixey T, Kelly M, Semin D, Hulme C. Tetrahedron Lett. 2002; 43: 3681
6c Hulme C, Bienaymé H, Nixey T, Chenera B, Jones W, Tempest P, Smith A. Methods Enzymol. 2003; 369: 469
6d Hulme C, Chappeta S, Dietrich J. Tetrahedron Lett. 2009; 50: 4054

7a Dietrich J, Kaiser C, Meurice N, Hulme C. Tetrahedron Lett. 2010; 51: 3951
7b Gunawan S, Ayaz M, De Moliner F, Frett B, Kaiser C, Patrick N, Hulme C. Tetrahedron 2012; 68: 5606
7c Shaw AY, Xu Z, Hulme C. Tetrahedron Lett. 2012; 53: 1998
7d Shaw AY, McLaren JA, Nichol GS, Hulme C. Tetrahedron Lett. 2012; 53: 2592
7e Ayaz M, Dietrich J, Hulme C. Tetrahedron Lett. 2011; 52: 4821
7f Shaw AY, Medda F, Hulme C. Tetrahedron Lett. 2012; 53: 1313

8 For a review, see: Banfi L, Riva R, Basso A. Synlett 2010; 23
9 Marcaccini S, Torroba T. Nat. Protoc. 2007; 2: 632

10a Wang W, Dömling A. J. Comb. Chem. 2009; 11: 403
10b Westermann B, Neuhaus C. Angew. Chem. Int. Ed. 2005; 44: 4077

11 General Procedure for the Preparation of Compounds 1a–g and 11a–e, Exemplified by Compound 1c tert-Butyl (2-aminophenyl)carbamate (1 equiv, 1.0 mmol, 208 mg) and ethyl glyoxylate (1.5 equiv, 1.5 mmol, 361 μL of a 50% solution in toluene) were dissolved in TFE (5 mL). After 10 min, N-Boc-glycine (1 equiv, 1.0 mmol, 175 mg) and 6-isocyano-2,3-dihydrobenzo[b][1,4]dioxane (1 equiv, 1.0 mmol, 161 mg) were added to the reaction mixture, which was stirred overnight at r.t. The reaction was monitored by LC–MS and TLC. Upon completion, the solvent was removed in vacuo and the crude material dissolved in 10% TFA–DCE (3.0 mL), with subsequent irradiation at 120 °C for 10 min. After the vial was cooled to r.t., the mixture was diluted with EtOAc (50 mL), and the organic layer was washed with sat. NaHCO₃ (20 × 2 mL) and brine. The organic phase was dried over MgSO₄, evaporated in vacuo, and the crude material was purified by flash chromatography (MeOH–EtOAc 0–10%) using an ISCO purification system to afford N-{2,3-dihydrobenzo-[b][1,4]dioxan-6-yl}-3-oxo-1,2,3,4-tetrahydrobenzo-[4,5]imidazo[1,2-a]pyrazine-4-carboxamide (1c) as a white solid (197 mg, 54% yield). ¹H NMR (400 MHz, DMSO-d ₆): δ = 10.89 (s, 1 H), 8.94–8.78 (m, 1 H), 7.68–7.58 (m, 1 H), 7.40 (dd, J = 6.2, 2.9 Hz, 1 H), 7.30–7.15 (m, 3 H), 7.01 (dd, J = 8.7, 2.3 Hz, 1 H), 6.81 (d, J = 8.7 Hz, 1 H), 5.74 (s, 1 H), 4.88–4.59 (m, 2 H), 4.19 (s, 4 H). ¹³C NMR (100 MHz, DMSO-d ₆): δ = 163.1, 162.5, 146.0, 143.2, 143.0, 140.1, 132.8, 131.5, 122.6, 122.3, 118.9, 117.0, 112.6, 109.5, 108.4, 64.1, 63.9, 60.6. MS: m/z = 365 [M + H]⁺. ESI-HRMS: m/z calcd for C₁₉H₁₇N₄O₄ [M + H]⁺: 365.1244; found: 365.1242.

For examples of the biological profiles displayed by the benzimidazole core, see:

12a Zarrinmayeh H, Nunes AM, Ornstein PL, Zimmerman DM, Arnold MB, Schober DA, Gackenheimer SL, Bruns RF, Hipskind PA, Britton TC, Cantrell BE, Gehlert DR. J. Med. Chem. 1998; 41: 2709
12b He Y, Yang J, Wu B, Risen L, Swayze EE. Bioorg. Med. Chem. Lett. 2004; 14: 1217
12c Horn J. Clin. Therap. 2000; 22: 266
12d Prichard MN, Frederick SL, Daily S, Borysko KZ, Townsend LB, Drach JC, Kern ER. Antimicrob. Agents Chemother. 2011; 55: 2442
12e Li Y, Tan C, Gao C, Zhang C, Luan X, Chen X, Liu H, Chen Y, Jiang Y. Bioorg. Med. Chem. 2011; 19: 4529

13 Dömling A, Huang Y. Synthesis 2010; 2859 ; and references cited therein
14 Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T. J. Med. Chem. 2011; 54: 2839

15a Xu Z, Shaw AY, Nichol GS, Cappelli AP, Hulme C. Mol. Diversity 2012; 16: 607
15b Xu Z, Ayaz M, Cappelli AP, Hulme C. ACS Comb. Sci. 2012; 14: 460